Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692

Antibodies to Coxsackie B viruses in congestive cardiomyopathy.

G Cambridge, C G MacArthur, A P Waterson, J F Goodwin, C M Oakley
PMCID: PMC482092  PMID: 223612

Abstract

Fifty patients with congestive cardiomyopathy have been studied for evidence of previous Coxsackie B virus infection and compared with age- and sex-matched controls who had been admitted to hospital for investigation of other cardiac diseases. High neutralisation titres (greater than or equal to 1024) to Coxsackie B viruses were more common among the controls. On subdividing the patients according to their length of symptomatic history before study, high titres were more common only in those with a short history (less than or equal to 1 year). High titres were more common when there had been a febrile illness at the onset of symptoms. Endomyocardial biopsies of 18 patients disclosed no evidence of myocarditis, or, in 12 cases, of viral involvement. Although the evidence remains circumstantial, these results support the theory that Coxsackie B viruses may cause congestive cardiomyopathy and encourage further research into the mechanisms of myocardial cell damage by these visuses.

Full text

PDF
692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burch G. E., Sun S. C., Colcolough H. L., Sohal R. S., DePasquale N. P. Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunofluorescent techniques. Am Heart J. 1967 Jul;74(1):13–23. doi: 10.1016/0002-8703(67)90035-x. [DOI] [PubMed] [Google Scholar]
  2. Dash H., Johnson R. A., Dinsmore R. E., Harthorne J. W. Cardiomyopathic syndrome due to coronary artery disease. I: Relation to angiographic extent of coronary disease and to remote myocardial infarction. Br Heart J. 1977 Jul;39(7):733–739. doi: 10.1136/hrt.39.7.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fletcher G. F., Coleman M. T., Feorino P. M., Marine W. M., Wenger N. K. Viral antibodies in patients with primary myocardial disease. Am J Cardiol. 1968 Jan;21(1):6–10. doi: 10.1016/0002-9149(68)90006-4. [DOI] [PubMed] [Google Scholar]
  4. Gau G. T., Goodwin J. F., Oakley C. M., Olsen E. G., Rahimtoola S. H., Raphael M. J., Steiner R. E. Q waves and coronary arteriography in cardiomyopathy. Br Heart J. 1972 Oct;34(10):1034–1041. doi: 10.1136/hrt.34.10.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodwin J. F., Oakley C. M. The cardiomyopathies. Br Heart J. 1972 Jun;34(6):545–552. doi: 10.1136/hrt.34.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grist N. R., Bell E. J. A six-year study of coxsackievirus B infections in heart disease. J Hyg (Lond) 1974 Oct;73(2):165–172. doi: 10.1017/s0022172400023998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grist N. R., Bell E. J., Reid D. The epidemiology of enteroviruses. Scott Med J. 1975 Jan;20(1):27–31. doi: 10.1177/003693307502000108. [DOI] [PubMed] [Google Scholar]
  8. KONNO S., SAKAKIBARA S. ENDO-MYOCARDIAL BIOPSY. Dis Chest. 1963 Oct;44:345–350. doi: 10.1378/chest.44.4.345. [DOI] [PubMed] [Google Scholar]
  9. Kawai C. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J. 1971 Jul;35(7):765–770. doi: 10.1253/jcj.35.765. [DOI] [PubMed] [Google Scholar]
  10. Lerner A. M., Wilson F. M. Virus myocardiopathy. Prog Med Virol. 1973;15:63–91. [PubMed] [Google Scholar]
  11. Levi G. F., Proto C., Quadri A., Ratti S. Coxsackie virus heart disease and cardiomyopathy. Am Heart J. 1977 Apr;93(4):419–421. doi: 10.1016/s0002-8703(77)80402-x. [DOI] [PubMed] [Google Scholar]
  12. Morris P. J., Pietsch M. C. Letter: A possible association between paralytic poliomyelitis and multiple sclerosis. Lancet. 1973 Oct 13;2(7833):847–848. doi: 10.1016/s0140-6736(73)90891-x. [DOI] [PubMed] [Google Scholar]
  13. SANDERS V. IDIOPATHIC DISEASE OF MYOCARDIUM. A PROSPECTIVE STUDY. Arch Intern Med. 1963 Nov;112:661–676. [PubMed] [Google Scholar]
  14. Sainani G. S., Krompotic E., Slodki S. J. Adult heart disease due to the Coxsackie virus B infection. Medicine (Baltimore) 1968 Mar;47(2):133–147. doi: 10.1097/00005792-196803000-00003. [DOI] [PubMed] [Google Scholar]
  15. Smith W. G. Coxsackie B myopericarditis in adults. Am Heart J. 1970 Jul;80(1):34–46. doi: 10.1016/0002-8703(70)90035-9. [DOI] [PubMed] [Google Scholar]
  16. Ward C., Gelsthorpe K., Doughty R. W. A relation between HLA antigens and clinical features in patients with acquired valvular heart disease. Br Med J. 1976 Jun 19;1(6024):1499–1501. doi: 10.1136/bmj.1.6024.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol. 1969 May;55(2):253–265. [PMC free article] [PubMed] [Google Scholar]
  18. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1. J Immunol. 1977 Apr;118(4):1159–1164. [PubMed] [Google Scholar]
  19. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1. J Immunol. 1977 Apr;118(4):1165–1169. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES